ClinicalTrials.gg
CompletedNCT05738109Updated Jun 14, 2024

Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal

An interventional study of Self-Talk Journals in Mental Health and Self Care, sponsored by University of Victoria. Completed at 1 site in Canada. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-14.

Sponsored by University of Victoria · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2022, registered Feb 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 154 studies in Psychological Well-Being with a site in Canada — 44 open to participants now, 58 under way, 1 of them phase 3. Psychological Well-Being · Canada.

Enrollment
77th of 126
67 · median 100
Started
2022
with 26 others
No phase
119 of 154
34 open now
Registered
100th of 154
by date

Among the 154 studies in Psychological Well-Being with a site in Canada, this one is the 77th largest by enrollment of the 126 interventional ones that give a count, is one of 27 that started in 2022, is one of 119 with no phase, and was the 100th registered.

Psychological Well-Being

2,197 studies on the registry are indexed under Psychological Well-Being; 729 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

44 of the 154 studies in Psychological Well-Being with a site in Canada are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 400 Psychological Well-Being studies recruiting now, 218 (55%) set no upper age limit and 156 (39%) stop at 75 or younger; 119 take children under 18; 203 take healthy volunteers.

This study: 19 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 154 studies in Psychological Well-Being with a site in Canada, or all of them as a file.
02

Study summary

  1. Does a 91-day self-talk journal intervention improve outcomes of self-criticism, self-esteem, automatic negative self-statements, and mental health among participants using the journal over wait-list control?
  2. What is the adherence rate to a 91-day self-talk journal intervention?
  3. What were participants' experience(s) of using a 91-day self-talk journal?
Read the detailed description

The following research project can contribute to the investigators' understanding of how/how well self-guided resources can increase participant outcomes of self-criticism, self-esteem, automatic negative self-statements, and mental health. Self-guided resources such as a self-talk journal provide can provide an easily accessible avenue for improving individual mental health. There has been a recent surge in the popularity of health-promotive self-care products, or products aimed at providing individuals with "the knowledge, skills, and attitudes required to achieve and maintain good health". These products (often in the form of journals) are similar to "self-help books"; however, a key difference is that self-care products prompt and provide space for the reader to actively engage in activities and psychological techniques, unlike the passive nature of traditional self-help books. These products typically address mental health concerns (i.e., mental health self-care) and are advertised to provide an effective means for individuals to reduce stress, improve self-compassion, and boost wellbeing. What's more, the generally positive reviews these products garner provides the perception that these products are well-received and effective in eliciting these outcomes. However, the scientific foundation for the majority of these journals is unknown. Furthermore, the efficacy of these products for improving or promoting their intended outcome(s) is often not addressed outside of these, often positive, reviews.

03

Conditions studied

  • Mental Health
  • Self Care

Keywords

  • mental health
  • self-care
  • self-talk
  • pilot trial
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

(1) being 19+ years old, (2) being fluent in English, (3) currently living in the Greater Victoria area, (4) self-reporting no previously diagnosed mental illness or psychiatric conditions, and (5) scoring >12 on the Self-Criticism subscale of the Self-Talk Scale (based on previous mean data; Brinthaupt, Hein, \& Kramer, 2009).

Exclusion criteria

Exclusion Criteria:

  • Scoring =\<12 on the Self-Talk Scale, currently receiving or seeking therapy for a mental illness, or a current or previous diagnosis of mental illness.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    Self-guided journaling Intervention

    Participants assigned to the waitlist group complete a 2wk, 1mo, 2mo and 3mo survey over the 91-day study period. After the 91-days they will also complete a follow-up survey and exit interview

    Other: Self-Talk Journals

  • No intervention
    Waitlist Control

    Participants assigned to the waitlist group complete a 2wk, 1mo, 2mo and 3mo survey over the 91-day study period. After the 91-days they receive access to the 91-day Self-Talk Journal for their own personal use.

Interventions

  • OtherSelf-Talk Journals

    Participants randomized to the intervention group will receive a physical copy of the 91-day self-talk journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Intervention participants will not be offered guidance or feedback on the journal after these initial instructions, in order to emulate an ad libitum usage. Control group participants will not receive any contact with the researchers outside of the planned questionnaires and to receive their journal at the three-month timepoint.

06

What researchers measure

Primary outcomes

  1. Self-Talk.

    Assessed using the Self-Talk Scale. The scale consists of 16 items rated on a five-point frequency scale (1 = never, 5 = very often) using the common stem "I talk to myself when…" It has a four factor-structure comprised of self-assessment, self-reinforcement, self-criticism and self-management. Total scores range from 16-80. Individual subscales scores range from 16-20. The higher the score the greater frequency of one's self-talk.

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

Secondary outcomes

  1. Self-esteem

    Assessed using the Rosenberg Self-Esteem Scale, a 10-item measure of global self-esteem or self-worth. Uses a 4-point likert scale ranging from 1 (strongly agree) to 4 (strongly disagree) Possible scores range from 10-40, higher scores indicate higher levels of self-esteem

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

  2. Self-consciousness

    Aspects of self-consciousness, including private self-consciousness, internal state awareness, self-reflection, public self-consciousness, and social anxiety, will be assessed using the Fenigstein Self-Consciousness Scale. The scale consists of 23 items, rated using a 5-point likert scale ranging from 0 (extremely uncharacteristic) to 4 (extremely characteristic), with higher scores denoting higher levels of self-consciousness.

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

  3. Automatic Negative Self-Statements

    The frequency of automatic negative self-statements will be assessed using the Automatic Thoughts Questionnaire, whose 30-items assess the frequency of negative self-statements associated with depression. Uses a 5-point likert scale comprised of the following: 1 = not at all, 2 = sometimes, 3 = moderately often, 4 = often , and 5 = all of the time. Possible scores range from 30-150, with higher scores indicating greater rates of negative self-statements.

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

  4. Adherence to Journal

    Adherence to the journal for the intervention group will be assessed using three items: 1. "Currently, what is the last day of the journal \[the participant\] completed?": possible score range 0-91, 0 indicates no days have been completed 2. "\[Has the participant\] skipped or not completed any days prior to the latest day \[the participant\] completed?": No or yes - indicate which days 3. "Approximately how many minutes \[did the participant\] spend completing a day, within the journal?": self-reported number of daily minutes

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

  5. Experience using the journal.

    Intervention group participants' experience using the journal will be assessed through a qualitative exit interview

    Time frame: At 3 months from baseline or if and when intervention participants drop out of the study

  6. Demographics

    Age, preferred gender, socio-economic status, ethnicity, educational attainment, and employment status will be collected

    Time frame: Baseline

  7. Mental Health

    Depression and anxiety will be assessed using the Hospital Anxiety and Depression Scale. Possible scores for each subscale range from 0-21. A score of 0-7 = "normal", 8-10 = "Borderline abnormal (borderline case)" and 11-21 = "Abnormal (case)."

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

  8. Subjective Well-Being

    Subjective well-being will be assessed using the Warwick-Edinburgh Mental Wellbeing Scale. Uses a 5-point Likert scale: 1= none of the time, 2= rarely, 3 = some of the time, 4 = often, and 5 = all of the time. Possible scores range from 14 to 70, with higher scores indicating greater mental-wellbeing

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

  9. Physical Activity, Sedentary Behaviour and Sleep

    Modified International Physical Activity Questionnaire includes open-ended questions surrounding individuals': 1. Physical activity. Frequency score ranging from 0-7 days per week. Average time spent on one of those days ranging from 0-24 total hours. Separate questions for vigorous intensity, moderate intensity, mild intensity and walking. 2. Sitting reported in average hours per day ranging from 0-24 total hours. 3. Occupational and recreational screentime. Reported using a separate daily average for weekdays and weekends ranging from 0-24 total hours. 4. Sleep reported using average number of hours per night ranging from 0-24 total hours.

    Time frame: Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants

07

Study locations

1 site
  • Behavioural Medicine Lab UVic
    Victoria, British Columbia V8p5C2, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Apr 2024, 19 months.

Of 1,263 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's 19 months is above that.

Counting every sponsor, half of 1,306 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2023
First posted
Feb 21, 2023
StartActual
Sep 13, 2022
Primary completionActual
Apr 30, 2024
CompletionActual
Apr 30, 2024
Last update
Jun 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05738109
Lead sponsor
University of Victoria
Collaborators
Switch Research, Mathematics of Information Technology and Complex Systems
Responsible party
Sponsor
First posted
Feb 21, 2023
Start date
Sep 13, 2022
Primary completion
Apr 30, 2024
Completion
Apr 30, 2024
Last update
Jun 14, 2024

Study contacts

Ryan Rhodes, PhD
principal investigator · Lab Director and Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion